Zydus Lifesciences, Maruti Suzuki India, Dabur India, South Indian Bank, Allcargo Logistics, International Conveyors, NMDC, ...

Aurobindo Pharma has also been granted competitive generic therapy designation for these Cephalexin Tablets, qualifying the ...

Last week, brokerage firm UBS Securities also initiated a 'sell' call on Aurobindo Pharma, assigning it a price target of Rs ...

Aurobindo Pharma receives USFDA approval for Cephalexin tablets, expected to launch in Q3FY25 with CGT designation.

The USFDA has issued 10 observations to Aurobindo Pharma's API manufacturing unit in Telangana after a September 2024 ...

Aurobindo Pharma gains FDA approval for Cephalexin Tablets, bioequivalent to Keflet, with CGT designation and shared exclusivity.

Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Cephalexin Tablets USP, 250 mg and 500 mg, which is bioequivalent and ...

The Hyderabad-based pharmaceutical manufacturing company said the observations are of procedural in nature and will be ...

Ruchit Jain of 5paisa has recommended two stocks today - Amara Raja Energy & Mobility Ltd, and Aurobindo Pharma Futures.

Aurobindo Pharma slipped 2.60% to Rs 1,470.45 after US Food and Drug Administration (USFDA) issued 10 observations to the company's wholly owned subsidiary, Apitoria Pharma's API manufacturing ...

Scope of complaint not limited to Vedanta or Aurobindo Pharma, will now get FIRs registered in other cases of ‘extortion’ of ...

Aurobindo Pharma's API facility in Hyderabad receives 10 observations from U.S. FDA, impacting parent company's stock price.